Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication

BACKGROUND: All Helicobacter pylori-infected patients are recommended for eradication with an appropriate regimen in each geographic area. The choice of the therapy is somewhat dependent on the antimicrobial susceptibility. The rate of clarithromycin resistance has been increasing and is associated...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ann Clin Microbiol Antimicrob
Main Authors: Tanabe, Hiroki, Yoshino, Keiichi, Ando, Katsuyoshi, Nomura, Yoshiki, Ohta, Katsuhisa, Satoh, Kiichi, Ichiishi, Eiichiro, Ishizuka, Akiei, Otake, Takaaki, Kohgo, Yutaka, Fujiya, Mikihiro, Okumura, Toshikatsu
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2018
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6022507/
https://ncbi.nlm.nih.gov/pubmed/29950163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12941-018-0281-x
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki